When should step-down therapy be considered in the management of inflammatory bowel disease (IBD)?

Updated: Oct 17, 2017
  • Author: William A Rowe, MD; Chief Editor: BS Anand, MD  more...
  • Print

Step-down therapy should be considered early in the management of patients with difficult or refractory disease. This approach uses immune modifiers or anti-TNF agents earlier in the treatment of the IBD patient than the step-up approach described earlier (see Overview of Stepwise Therapy, above).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!